Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$612,344
+$17,014 QoQ
Shares Held
1,691
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#2,041
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TCI Wealth Advisors, Inc. holds $24,505,177 across 8 Drug Manufacturers - General names. AMGN ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,577 | $9,797,400 | |
| 2 | LLY |
ELI LILLY & Co
|
6,824 | $8,184,911 | |
| 3 | ABBV |
AbbVie Inc.
|
15,431 | $3,883,056 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,242 | $1,187,597 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,691 | $612,344 | |
| 6 | PFE |
Pfizer Inc
|
15,257 | $367,388 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,558 | $262,631 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,661 | $209,850 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $612,344 | 1,691 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $595,330 | 1,692 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $885,046 | 2,704 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $761,657 | 2,699 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $752,191 | 2,694 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,017,210 | 3,265 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $921,623 | 3,536 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,181,866 | 3,668 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,232,927 | 3,946 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,102,877 | 3,879 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,116,365 | 3,876 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,083,371 | 4,031 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $876,979 | 3,950 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $995,768 | 4,119 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,087,854 | 4,142 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $914,447 | 4,057 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $977,579 | 4,018 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $971,632 | 4,018 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $758,823 | 3,373 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $700,043 | 3,292 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $866,531 | 3,555 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $872,327 | 3,506 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,200,182 | 5,220 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $2,503,984 | 9,852 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,323,692 | 9,852 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,011,284 | 9,921 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||